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EBV strains with predominantly low transforming capacity of
LMP1 are persisting. These findings are likely can explain the
non-endemic nature of the EBV-associated pathologies in
Russia.On the other hand, one can speculate that in African
countries which are endemic for BL highly oncogenic strains of
EBV are dominated, the indirect confirmation of what is the
detection in cell lines of BL origin LMP1 isolates having high
transforming activity. The results of this study let us also to
suggest that LMP1 expression pattern in non-endemic region like
Russia does not reflect the type of malignancy but rather reflect
their geographic origin.
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The Hsp70 chaperone is one of themajor components of tumor
microenvironment displaying multiple not yet established func-
tions. It was shown to stimulate innate and adaptive anti-tumor
immunity in a variety of cancer models. These effects were due
to active release of endogenous Hsp70 to an extracellular matrix
and therefore the extracellular chaperone can be a trigger of
multiple events in the whole tumor. Factors inducing Hsp70
release are heat stress, inhibitors of important signaling proteins,
anticancer drugs and X-ray treatment. Recently we have shown
that delivery of Hsp70 can be efficient pusher of its intracellular
analogue to extracellular milieu. In this study we show that
intracellular cycling of exo- and endogenous Hsp70s increases
the sensitivity of cancer cells to cytotoxic lymphocytes. Moreover,
the results of in vivo studies employing B16 mouse melanoma
and C6 rat glioblastoma as targets proved the therapeutic
relevance of exogenous Hsp70 in intra-tumoral application.
To uncover the mechanisms of the anticancer effect we used
inhibitors and markers of intra- and extracellular protein trans-
port. The data of these studies showed multiplicity of pathways
using which exo-Hsp70 reaches cytosol and more usable ones
was endocytosis. To be exported intracellular Hsp70 employs
vesicular structures as well as intra-membrane lipid structures.
Analyzing Hsp70 molecule we found the domain with poten-
tial vector activity, i.g. cell penetrating function. This peptide
was synthesized and shown to cross a cellular membrane with
efficacy exceeding that the whole Hsp70 molecule. Furthermore,
the new peptide was used as a carrier for the delivery inside living
cells antibody to Hsp70. The resulting construct was found to
reduce the resistance of tumor cells to pro-apoptotic effect of
staurosporin.
Taking together these data, we can suggest that Hsp70 and its
fragments can be effective players in communication between
cells assembling functionally active tumor.
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Aberrant alterations of DNA methylation patterns have been
recognized as early and common events in oncogenesis empha-
sizing high therapeutic and preventive potential. Concurrent epi-
genetic silencing of multiple tumour suppressor genes has been
reported in different tumours suggesting the existence of a direc-
ted program, whereby groups of genes are regulated by promoter
methylation. The molecular bases of such a program remain lar-
gely unclear. Certain long non-coding RNAs (lncRNAs) have been
recently identified that are responsible for target specificity of the
histone modification complexes. It remains incompletely under-
stood, however, if lncRNAs may play a role in patterning DNA
methylation. In this study, we asked by using gastrointestinal
stromal tumours as a model if an epigenetic related HOX Antisense
Intergenic RNA, or HOTAIR, is involved in establishment of DNA
methylation patterns. To this end, we first showed high up-
regulation of HOTAIR in patient samples of high risk compared
to low and intermediate risk groups (n = 66, p = 6.7  106), what
is supported by the earlier reports on common carcinomas. High-
est levels of HOTAIR endogenous expression were next detected
also in cell lines GIST T1, GIST48b and GIST882. Stable knockdown
of HOTAIR was achieved in GIST T1 and GIST48b cells by RNAi
using lentiviral transduction. As expected epigenetic alterations
due to HOTAIR knockdown could develop with a delay, genome-
wide DNA methylation profiling was performed at passage 12
after the transduction on the Infinium HumanMethylation450
BeadChip platform in triplicates. DNA methylation data were
analysed by an R package RnBeads. A total of 218 CpG sites got
hypomethylated upon HOTAIR knockdown in GIST T1 and
GIST48b cells (Db > 0.3, FDR < 0.05). These included potential
tumour suppressors, transcription factors, tumour-specific anti-
gens, genes related to angiogenesis or involved in metabolism.
As confirmed by using bisulfite pyrosequencing for a representa-
tive locus, DNAmethylation of 64% degree at promoter associated
CpG sites of the potential tumour suppressor RASSF1 was almost
entirely erased upon HOTAIR knockdown in GIST T1 cell line with
concomitant up-regulation detected by qRT-PCR. Concordant
with earlier reports, HOTAIR knockdown led to reduced migration
potential in GIST T1 cells. Taken together, the results suggest that
HOTAIR is one of the factors involved in establishment of specific
DNA methylation patterns in GIST. While the molecular mecha-
nism remains to be determined, it is plausible to assume a
recruitment of DNA methyltransferases by the Polycomb repres-
sive complex 2, which target specificity is determined by HOTAIR.
The results further suggest the feasibility of manipulating DNA
methylation patterns in a targeted manner and are of potential
interest in context of developing epigenetic cancer therapy.
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